This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Swiss Competition Authority: WEKO fines Pfizer, Eli Lilly and Bayer for recommendation list for certain drugs

( December 1, 2009, 08:24 GMT | Official Statement) -- MLex Summary: The Swiss competition authority has fined pharmaceuticals companies Pfizer, Eli Lilly and Bayer 5.7 million Swiss Francs (3.77 million euros) for pricing practices for certain drugs. The regulator found that the so-called 'Hors-Liste Medikamente' price recommendations drawn up by the drugs companies, and the distributors who agreed to adhere to them, infringe Swiss competition law.At issue is the pricing policy for erectile dysfunction drugs Viagra, Cialis and Levitra....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections